Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Current Assets (2023 - 2026)

Cannabis Bioscience International Holdings' Current Assets history spans 4 years, with the latest figure at $1544.0 for Q1 2026.

  • On a quarterly basis, Current Assets fell 59.22% to $1544.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $1544.0, a 59.22% decrease, with the full-year FY2025 number at $29085.0, up 35.33% from a year prior.
  • Current Assets hit $1544.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $22131.0 in the prior quarter.
  • Over the last five years, Current Assets for CBIH hit a ceiling of $29085.0 in Q2 2025 and a floor of $1544.0 in Q1 2026.
  • Historically, Current Assets has averaged $17161.5 across 4 years, with a median of $18942.0 in 2025.
  • The widest YoY moves for Current Assets: up 43.53% in 2025, down 79.46% in 2025.
  • Tracing CBIH's Current Assets over 4 years: stood at $19739.0 in 2023, then fell by 21.89% to $15419.0 in 2024, then surged by 43.53% to $22131.0 in 2025, then plummeted by 93.02% to $1544.0 in 2026.
  • Business Quant data shows Current Assets for CBIH at $1544.0 in Q1 2026, $22131.0 in Q4 2025, and $18942.0 in Q3 2025.